about
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarctionIn vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium.Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsMagnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque.HDL as a contrast agent for medical imaging.An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopesThe complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaques.Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction.Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T.MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor.
P50
Q30436299-DB012D69-4C92-41D2-B2EE-778672A6B6BBQ30493876-7F86987E-E13D-42FA-9E16-92813A345219Q30539291-759BBFD8-3257-46DE-8EAE-8881A356C3ADQ33268808-A47468F4-9D39-4242-82EB-186818885F11Q33392047-C29142D1-6809-4B78-B94B-1AC14C21C04DQ34518372-24EB51AF-483B-4946-8C07-17292D709CECQ36923150-2D9B2852-24C2-43F6-BC2F-3C38F1FC82A6Q37395788-86E8F5C4-3F55-40AA-8FE6-FDD203AAA8ADQ38713992-6F748544-B35D-474A-87AF-8DAF9D0FF8F7Q39296175-6B217DC5-CB79-4DD9-AE22-DDF51620C3DEQ39813598-2636BF4E-1ABD-4127-A611-EEC5428E48DBQ39949344-3E2847F8-2F0C-4F54-BF5E-3A41788CEDD1Q41370572-35ADD44A-C4E1-4601-96B2-C0B45389677DQ41964030-63CADE3A-A725-49AF-BBE3-2E37D6BF3251Q48878843-4EF831FA-CFD0-4B38-897C-1E0F1F6AB626Q51306514-895CF4A5-E01A-4AF7-ABB6-84F6A4A8C6DDQ53524952-5A753BF9-BE62-4EF0-B5B5-769676B0EFC3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karen Briley
@ast
Karen Briley
@en
Karen Briley
@es
Karen Briley
@nl
Karen Briley
@sl
type
label
Karen Briley
@ast
Karen Briley
@en
Karen Briley
@es
Karen Briley
@nl
Karen Briley
@sl
altLabel
Karen Briley-Saebo
@en
prefLabel
Karen Briley
@ast
Karen Briley
@en
Karen Briley
@es
Karen Briley
@nl
Karen Briley
@sl
P108
P106
P21
P31
P496
0000-0001-5402-8779